329 related articles for article (PubMed ID: 10623111)
1. Biotech bonanza.
Stipp D
Fortune; 1999 Nov; 140(9):333-4. PubMed ID: 10623111
[No Abstract] [Full Text] [Related]
2. Nasdaq restructures biotech index.
Morrison C
Nat Biotechnol; 2001 Mar; 19(3):187. PubMed ID: 11231518
[No Abstract] [Full Text] [Related]
3. Rising costs hold up drug discovery.
Miller HI
Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
[No Abstract] [Full Text] [Related]
4. Spinning the wheel on ImClone.
Varchaver N
Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
[No Abstract] [Full Text] [Related]
5. How the street sees biotech.
Lashinsky A
Fortune; 2003 Jun; 147(11):86. PubMed ID: 12800576
[No Abstract] [Full Text] [Related]
6. Public biotech 98: the numbers.
Lähteenmäki R; Michael A; Marshall A
Nat Biotechnol; 1999 May; 17(5):429-32. PubMed ID: 10331795
[No Abstract] [Full Text] [Related]
7. Frustrated by regulatory delays at FDA, biotech companies warm to user fees.
Gershon D
Nature; 1992 Aug; 358(6388):616. PubMed ID: 1495553
[No Abstract] [Full Text] [Related]
8. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Reed SD; Califf RM; Schulman KA
Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
[TBL] [Abstract][Full Text] [Related]
9. A special biotech speculation.
Jacobs T
Nat Biotechnol; 2006 Jun; 24(6):622. PubMed ID: 16763586
[No Abstract] [Full Text] [Related]
10. Biotech jostles with pharma for slice of HIV market.
Katsnelson A
Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
[No Abstract] [Full Text] [Related]
11. Beyond the lab in biotech. With so many drugs in trial, new jobs are opening up.
Carmichael M
Newsweek; 2002 Sep; 140(13):53. PubMed ID: 12375414
[No Abstract] [Full Text] [Related]
12. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
13. Does biotech M&A benefit investors?
Jacobs T
Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
[No Abstract] [Full Text] [Related]
14. Biotech entrepreneurs swoon over proposed fundraising changes.
Venkataramanan M
Nat Med; 2012 Jan; 18(1):3. PubMed ID: 22227645
[No Abstract] [Full Text] [Related]
15. Investing in oncology biotech stocks.
Feuerstein A
Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
[No Abstract] [Full Text] [Related]
16. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
17. How Genentech got it.
Stipp D
Fortune; 2003 Jun; 147(11):81-2, 84, 86 passim. PubMed ID: 12800575
[No Abstract] [Full Text] [Related]
18. Biotech companies adapt to big pharma mergers.
Niiler E
Nat Biotechnol; 2000 May; 18(5):487-8. PubMed ID: 10802607
[No Abstract] [Full Text] [Related]
19. Biotech slumps in Q1.
Lawrence S
Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
[No Abstract] [Full Text] [Related]
20. BioXell: an Italian biotech success story?
Sheridan C
Nat Biotechnol; 2006 Sep; 24(9):1045-6. PubMed ID: 16964198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
